Distinct intrathecal inflammatory signatures following relapse and anti-COVID-19 mRNA vaccination in multiple sclerosis.

Antonio BrunoFabio ButtariEttore DolcettiFederica AzzoliniAngela BorrelliGianluca LauritanoVeronica Di CaprioFrancesca Romana RizzoLuana GilioGiovanni GalifiRoberto FurlanAnnamaria FinardiLivia GuadalupiAlessandra MusellaGeorgia MandolesiDiego CentonzeMario Stampanoni Bassi

Published in: Multiple sclerosis (Houndmills, Basingstoke, England) (2023)

Vaccine for COVID-19 induces a central inflammatory response in RRMS patients that is qualitatively different from that associated with disease relapse.

Keyphrases

coronavirus disease
multiple sclerosis
inflammatory response
sars cov
end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
dna methylation
lps induced
immune response